Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:analgesic_effect |
potent
|
| gptkbp:analogue_of |
gptkb:U-47700
gptkb:U-50488 |
| gptkbp:chemicalFormula |
C20H26N2O
|
| gptkbp:class |
opioid
|
| gptkbp:developedBy |
gptkb:Upjohn
|
| https://www.w3.org/2000/01/rdf-schema#label |
UC-50
|
| gptkbp:IUPACName |
N-[2-(dimethylamino)cyclohexyl]-N-methylnaphthalene-1-carboxamide
|
| gptkbp:legalStatus |
uncontrolled (most countries)
|
| gptkbp:relatedTo |
gptkb:U-47700
gptkb:U-50488 AH-7921 MT-45 U-48800 |
| gptkbp:routeOfAdministration |
oral
intravenous intranasal |
| gptkbp:sideEffect |
respiratory depression
sedation addiction potential euphoria |
| gptkbp:year_of_development |
1970s
|
| gptkbp:bfsParent |
gptkb:Liaquatabad
|
| gptkbp:bfsLayer |
7
|